There is ample evidence that the angiotensin-receptor/neprilysin inhibitor is superior to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in achieving cardiac reverse remodeling in patients with HF and reduced LVEF [35], leading to a reduction in FMR grade [11]. Here, ACE is linked to hydrops fetalis.